. 2020 Oct 21;14(1):100900. doi: 10.1016/j.tranon.2020.100900

Table 4.

POFUT1 survival analysis of patient subgroups with less aggressive characteristics.

Subgroup	Survival	Gene	p-Value	p-Value strength	Group size [n]	Group distribution	5-year survival rate
Subgroup	Survival	Gene	p-Value	p-Value strength	Group size [n]	Low [%]	High [%]	Low [%]	High [%]
	OS	POFUT1	0.0014	**	104	73	27	36	78
	CSS	POFUT1	0.0007	***	92	71	29	41	73
	DFS	POFUT1	0.0088	**	86	72	28	40	61
T2/3	OS	POFUT1	0.0056	**	80	30	70	28	73
T2/3	CSS	POFUT1	0.0121	*	71	34	66	44	76
T2/3	DFS	POFUT1	0.0433	*	71	31	69	44	76
pN−	OS	POFUT1	0.0073	**	72	69	31	40	78
pN−	CSS	POFUT1	0.0058	**	65	66	34	35	59
pN−	DFS	POFUT1	0.0079	**	64	69	31	44	75
male	OS	POFUT1	0.0101	*	77	71	29	27	67
male	CSS	POFUT1	0.0088	**	68	74	26	42	84
male	DFS	POFUT1	0.0502	ns	63	75	25	43	83

Partition test for cut offs and log rang test were applied. The group distributions and 5-year survival rates are divided into groups representing high and low POFUT1 gene expression. Overall survival (OS); cancer-specific survival (CSS); disease-free survival (DFS); tumor stage T2a/b and T3a/b (T2/3); lymph node metastasis absent (pN−); only male patients within this subgroup (male); not significant (ns); significant p-values are displayed in bold.